ipilimumab,nivolumab,durvalumab,vinorelbine,paclitaxel,carboplatin,cisplatin,gemcitabine,docetaxel,pemetrexed
bms,astrazeneca
[]
 #1 patient wants surgery
#2 surgery required for an r0 resection is compatible with acceptable safety and qol for the patient, their loved ones and the surgeon
#3 what is considered acceptable is a mix of the patient s goals of care and the surgeon s skill/risk tolerance
Medical Director of the McGill Thoracic Oncology Program; Chest surgeon; Neutrophil biologist; Cancer immunologist; Aspiring farmer